Drug or treatment
Larotrectinib clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Larotrectinib that are recruiting, at sites in 6 countries (most in United States (3), Japan (1), Australia (1)). By phase: Phase 2 (2), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 6Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using Larotrectinib to Improve Radioactive Iodine Treatment in Thyroid Cancer | Phase 2 | San Francisco, California and 5 other locations | Recruiting | Mar 24, 2023 |
| Using larotrectinib for advanced or recurrent solid tumors with NTRK gene fusion | — | Multiple Locations | Recruiting | Jun 30, 2021 |
| Treatment of advanced solid tumors with larotrectinib for NTRK gene amplification | Phase 2 | Houston, Texas | Recruiting | May 10, 2021 |
| Using Larotrectinib for Children with Newly Diagnosed High-Grade Glioma with NTRK Fusion | Early Phase 1 | Aurora, Colorado and 20 other locations | Recruiting | Dec 7, 2020 |
All recruiting trials (4)
-
Using Larotrectinib to Improve Radioactive Iodine Treatment in Thyroid Cancer
This study is testing if adding a drug called larotrectinib to radioactive iodine treatment can help people with a specific type of thyroid cancer that has spread to the lungs feel better.
-
Using larotrectinib for advanced or recurrent solid tumors with NTRK gene fusion
This study is testing how well larotrectinib works for adults and children with advanced or recurrent solid tumors caused by NTRK gene fusions.
-
Treatment of advanced solid tumors with larotrectinib for NTRK gene amplification
This study is testing if a new drug called larotrectinib can help people with advanced solid tumors that have a specific gene change called NTRK amplification.
-
Using Larotrectinib for Children with Newly Diagnosed High-Grade Glioma with NTRK Fusion
This study is testing if a new drug called larotrectinib can help children with a specific type of brain cancer called high-grade glioma that has an NTRK fusion.
Quick answers
How many clinical trials of Larotrectinib are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (3 trials), Japan (1 trial), Australia (1 trial), Canada (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.